Sien Zhao
Shengli Street 1160
Yinchuan, 750004, China
Yinchuan, 750004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
SOCS2 inhibits the tumorigenesis of GISTs and increases the sensitivity of GISTs to imatinib by suppression of KIT activation.
Journal: Scientific reports
Published: October 21, 2024
LncRNA CCAT2 promotes the proliferation and metastasis of colorectal cancer through activation of the ERK and Wnt signaling pathways by regulating GNB2 expression.
Journal: Cancer medicine
Published: April 07, 2024
Four and a half LIM domains 2 (FHL2) attenuates tumorigenesis of gastrointestinal stromal tumors (GISTs) by negatively regulating KIT signaling.
Journal: Molecular carcinogenesis
Published: January 16, 2024
DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors.
Journal: Molecular carcinogenesis
Published: June 30, 2023
SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: April 02, 2023
Farnesyltransferase (FTase) Inhibitors Increase Inhibition of KIT Mutants by Imatinib.
Journal: Reports of biochemistry & molecular biology
Published: November 27, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026